Sino Biopharmaceutical (OTCMKTS:SBMFF) Short Interest Down 49.2% in July

Sino Biopharmaceutical (OTCMKTS:SBMFF) was the target of a significant decrease in short interest in the month of July. As of July 31st, there was short interest totaling 27,548,732 shares, a decrease of 49.2% from the July 15th total of 54,218,169 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ? days. Approximately 0.1% of the shares of the stock are sold short.

Sino Biopharmaceutical Trading Up 6.7%

Shares of Sino Biopharmaceutical stock opened at $0.65 on Tuesday. Sino Biopharmaceutical has a 12-month low of $0.59 and a 12-month high of $1.24. The firm’s 50-day moving average price is $0.62 and its two-hundred day moving average price is $0.72.

About Sino Biopharmaceutical

Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) is a Hong Kong–incorporated investment holding company principally engaged in the pharmaceutical sector. Founded in 2000 and listed on the Hong Kong Stock Exchange in 2006, the company has developed an integrated business model that spans research and development, manufacturing and commercialization of healthcare products. Through its subsidiaries, Sino Biopharmaceutical focuses on enhancing China’s domestic pharmaceutical infrastructure while expanding its footprint across key therapeutic areas.

The company’s product portfolio is organized into three core segments: infusion solutions, small-molecule synthetic pharmaceuticals and innovative biologics.